UAE Intravenous Solutions Market Size & Outlook, 2023-2030
UAE intravenous solutions market, 2018-2030 (US$M)
Related Markets
UAE intravenous solutions market highlights
- The UAE intravenous solutions market generated a revenue of USD 68.6 million in 2023 and is expected to reach USD 97.2 million by 2030.
- The UAE market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
- In terms of segment, total parenteral nutrition was the largest revenue generating product in 2023.
- Total Parenteral Nutrition is the most lucrative product segment registering the fastest growth during the forecast period.
Intravenous solutions market data book summary
| Market revenue in 2023 | USD 68.6 million |
| Market revenue in 2030 | USD 97.2 million |
| Growth rate | 5.1% (CAGR from 2023 to 2030) |
| Largest segment | Total parenteral nutrition |
| Fastest growing segment | Total Parenteral Nutrition |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Total Parenteral Nutrition, Peripheral Parenteral Nutrition |
| Key market players worldwide | Fresenius SE & Co KGaA, Fresenius Kabi, Pfizer Inc, Otsuka Pharmaceutical, Baxter International Inc, B. Braun, JW Life Sciences, CSL Ltd |
Other key industry trends
- In terms of revenue, UAE accounted for 0.5% of the global intravenous solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa intravenous solutions market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 251.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intravenous Solutions Market Scope
Intravenous Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE intravenous solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous solutions market will help companies and investors design strategic landscapes.
Total parenteral nutrition was the largest segment with a revenue share of 65.89% in 2023. Horizon Databook has segmented the UAE intravenous solutions market based on total parenteral nutrition, peripheral parenteral nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
During cancer treatment, nutrition plays an important role as the immunity level of the patient suffering from cancer needs to be high to sustain various treatment procedures, such as surgery, chemotherapy, radiation therapy, immunotherapy, and stem cell implants for head, neck, esophagus, stomach, or intestine.
It was identified that most head and neck cancer patients decrease their oral intake due to pain when swallowing solid foods. Malnutrition can result in low immunity in cancer patients, reducing their chances of surviving cancer treatment.
Hence, good nutrition through the parenteral mode can contribute by relieving these adverse effects, preventing treatment delays, weight loss, and accelerating recovery.
Reasons to subscribe to UAE intravenous solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE intravenous solutions market databook
-
Our clientele includes a mix of intravenous solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE intravenous solutions market , including forecasts for subscribers. This country databook contains high-level insights into UAE intravenous solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE intravenous solutions market size, by product, 2018-2030 (US$M)
UAE Intravenous Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
